BBIBP-CorV COVID-19 vaccine

URI: https://gptkb.org/entity/BBIBP-CorV_COVID-19_vaccine

GPTKB entity

Statements (73)

Predicate	Object
gptkbp:instanceOf	vaccine
gptkbp:alsoKnownAs	gptkb:Sinopharm_BIBP_COVID-19_vaccine gptkb:BBIBP-CorV
gptkbp:antigen	inactivated SARS-CoV-2 virus
gptkbp:approvedBy	gptkb:Argentina gptkb:Bahrain gptkb:Bangladesh gptkb:Bolivia gptkb:Cambodia gptkb:Chile gptkb:China gptkb:Colombia gptkb:Dominican_Republic gptkb:Ecuador gptkb:Egypt gptkb:Gabon gptkb:Guinea gptkb:Guyana gptkb:Hungary gptkb:Indonesia gptkb:Iran gptkb:Iraq gptkb:Jordan gptkb:Laos gptkb:Malaysia gptkb:Mauritania gptkb:Mexico gptkb:Mongolia gptkb:Morocco gptkb:Nepal gptkb:Niger gptkb:Nigeria gptkb:Pakistan gptkb:Paraguay gptkb:Peru gptkb:Philippines gptkb:Senegal gptkb:Serbia gptkb:Seychelles gptkb:Sierra_Leone gptkb:Sri_Lanka gptkb:Thailand gptkb:Togo gptkb:Turkey gptkb:Uganda gptkb:United_Arab_Emirates gptkb:Uruguay gptkb:Uzbekistan gptkb:Venezuela gptkb:World_Health_Organization gptkb:Zimbabwe 2020
gptkbp:category	gptkb:COVID-19_pandemic Vaccines Chinese inventions
gptkbp:clinicalTrialPhase	gptkb:Bahrain gptkb:Egypt gptkb:Jordan gptkb:Peru gptkb:United_Arab_Emirates
gptkbp:developedBy	gptkb:Sinopharm
gptkbp:dosesRequired	2
gptkbp:efficacyAgainstSymptomaticCOVID19	79%
gptkbp:emergencyServices	gptkb:World_Health_Organization
https://www.w3.org/2000/01/rdf-schema#label	BBIBP-CorV COVID-19 vaccine
gptkbp:intervalBetweenDoses	3–4 weeks
gptkbp:manufacturer	gptkb:Sinopharm gptkb:Beijing_Institute_of_Biological_Products
gptkbp:routeOfAdministration	intramuscular
gptkbp:storage	2–8°C
gptkbp:target	gptkb:COVID-19
gptkbp:bfsParent	gptkb:Beijing_Institute_of_Biological_Products
gptkbp:bfsLayer	6